| Racial Disparities in Outcomes of Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Secondary to Spontaneous Coronary Artery Dissection A Chaturvedi, HM Garcia-Garcia, M Cellamare, C Zhang, P Chandrika, ... The American Journal of Cardiology, 2024 | | 2024 |
| Impella versus Non-Impella for Non-Emergent High-Risk Percutaneous Coronary Intervention P Reddy, I Merdler, C Zhang, M Cellamare, I Ben-Dor, NL Bernardo, ... The American Journal of Cardiology, 2024 | | 2024 |
| Impact of Significant Hemoglobin Drop Without Bleeding in Patients Undergoing Transcatheter Aortic Valve Replacement P Reddy, I Merdler, C Zhang, M Cellamare, I Ben‐Dor, LF Satler, ... Journal of the American Heart Association, e032291, 2024 | | 2024 |
| Temporal trends with the Evolut family of self‐expanding transcatheter heart valves: A single‐center experience I Merdler, BC Case, S Bhogal, PK Reddy, C Zhang, S Ali, PE Gallino, ... Catheterization and Cardiovascular Interventions, 2024 | 1 | 2024 |
| Markedly elevated high-sensitivity troponin and in-hospital mortality after cardiac surgery P Reddy, M Cellamare, I Merdler, C Zhang, S Bhogal, AI Aladin, I Ben-Dor, ... Cardiovascular Revascularization Medicine, 2024 | | 2024 |
| Frequency of ventriculography during left heart catheterization for radial vs. femoral access I Merdler, BC Case, M Cellamare, S Bhogal, PK Reddy, C Zhang, ... Cardiovascular Revascularization Medicine, 2024 | 1 | 2024 |
| Comparing planned versus ad hoc coronary microvascular assessment: Early findings from the Coronary Microvascular Disease Registry I Merdler, N Bazarbashi, GA Medranda, C Zhang, ST Ozturk, V Sawant, ... Cardiovascular Revascularization Medicine, 2024 | 1 | 2024 |
| Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects I Merdler, R Wallace, A Banerjee, GA Medranda, P Reddy, M Cellamare, ... Catheterization and Cardiovascular Interventions 103 (5), 703-709, 2024 | | 2024 |
| From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunction I Merdler, R Wallace, AP Hill, KR Chitturi, GA Medranda, P Reddy, ... Cardiovascular Revascularization Medicine, 2024 | 1 | 2024 |
| Coronary Microvascular Disease Registry (CMDR): Study design and rationale BC Case, I Merdler, GA Medranda, C Zhang, ST Ozturk, V Sawant, ... Cardiovascular Revascularization Medicine, 2024 | | 2024 |
| The impact of cusp overlap on permanent pacemaker requirement following self-expanding transcatheter aortic valve replacement GA Medranda, T Rogers, BC Case, C Zhang, M Cellamare, C Shea, ... Cardiovascular Revascularization Medicine 59, 9-13, 2024 | 1 | 2024 |
| Self-expanding and balloon-expandable valves in low risk TAVR patients S Bhogal, R Waksman, C Shea, C Zhang, P Gordon, A Ehsan, SR Wilson, ... International Journal of Cardiology 395, 131431, 2024 | 2 | 2024 |
| Investigating Electrocardiographic Abnormalities in Patients with Coronary Microvascular Dysfunction I Merdler, A Hill, ST Ozturk, M Cellamare, C Zhang, A Banerjee, ... medRxiv, 2024.04. 21.24306154, 2024 | | 2024 |
| Gender disparities related to clinical characteristics and outcomes of patients undergoing transseptal procedures AI Aladin, T Arar, F Lubaina, S Bhogal, C Zhang, JP Wermers, I Ben-Dor, ... Cardiovascular Revascularization Medicine 58, 45-49, 2024 | | 2024 |
| Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes AI Aladin, JP Wermers, C Zhang, BC Case, I Ben‐Dor, S Bhogal, ... Catheterization and Cardiovascular Interventions 102 (7), 1177-1185, 2023 | | 2023 |
| Correspondence regarding a published study: Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative … C Zhang, I Merdler, R Waksman Cardiovascular revascularization medicine: including molecular interventions …, 2023 | | 2023 |
| Association of acute stroke with COVID-19 at a large healthcare system before and during pandemic BC Case, A Hill, O Waksman, H Rappaport, C Zhang, R Waksman Cardiovascular revascularization medicine: including molecular interventions …, 2023 | | 2023 |
| Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVR I Merdler, B Case, S Bhogal, PK Reddy, V Sawant, C Zhang, S Ali, ... Cardiovascular Revascularization Medicine 56, 1-6, 2023 | 4 | 2023 |
| Aspirin versus warfarin after transcatheter aortic valve replacement in low-risk patients: 2-year follow-up I Merdler, T Rogers, BC Case, S Bhogal, PK Reddy, I Ben-Dor, C Zhang, ... The American Journal of Cardiology 206, 108-115, 2023 | 3 | 2023 |
| Disparities in Screening and Enrollment of Minorities Into Cardiovascular Clinical Trials BC Case, I Merdler, EC Collins, M Deville, H Rappaport, M Cellamare, ... Cardiovascular Interventions 16 (20), 2578-2580, 2023 | 1 | 2023 |
